HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.

Abstract
Parathyroid hormone-related protein (PTHrP) is expressed by human prostatic tissues and cancer cell lines. PTHrP enhances tumor cell growth and metastasis in vivo and up-regulates proinvasive integrin alpha6beta4 expression in vitro. Hallmarks of malignant tumor cells include resistance to apoptosis and anchorage-independent cell growth. In this study, we used the human prostate cancer cell lines C4-2 and PC-3 as model systems to study the effects of PTHrP on these processes. We report that PTHrP protects these cells from doxorubicin-induced apoptosis and promotes anchorage-independent cell growth via an intracrine pathway. Conversely, autocrine/paracrine PTHrP action increases apoptosis in C4-2 cells and has no effect on apoptosis in PC-3 cells. The intracrine effects of PTHrP on apoptosis are mediated via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. PTHrP also affects the phosphorylation state of Akt substrates implicated in apoptosis suppression, including glycogen synthase kinase-3 and Bad. The prosurvival effects of PTHrP are accompanied by increases in the ratio of antiapoptotic to proapoptotic members of the Bcl-2 family and in levels of c-myc. PTHrP also increases nuclear factor-kappaB activity via a PI3K-dependent pathway. Integrin alpha6beta4 is known to activate PI3K. Here, we also show that knockdown of integrin alpha6beta4 negates the PTHrP-mediated activation of the PI3K/Akt pathway. Taken together, these observations provide evidence of a link between PTHrP and the PI3K/Akt signaling pathway through integrin alpha6beta4, resulting in the activation of survival pathways. Targeting PTHrP production in prostate cancer may thus prove therapeutically beneficial.
AuthorsVandanajay Bhatia, Ramanjaneya V Mula, Nancy L Weigel, Miriam Falzon
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 7 Issue 7 Pg. 1119-31 (Jul 2009) ISSN: 1557-3125 [Electronic] United States
PMID19584267 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Integrin alpha6beta4
  • NF-kappa B
  • Parathyroid Hormone-Related Protein
  • Proto-Oncogene Proteins c-bcl-2
  • Proto-Oncogene Proteins c-myc
  • Receptor, Parathyroid Hormone, Type 1
  • Doxorubicin
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
Topics
  • Analysis of Variance
  • Apoptosis (drug effects)
  • Cell Adhesion (physiology)
  • Cell Growth Processes (physiology)
  • Cell Line, Tumor
  • Cell Survival (physiology)
  • Doxorubicin (pharmacology)
  • Enzyme Activation
  • Glycogen Synthase Kinase 3 (metabolism)
  • Humans
  • Integrin alpha6beta4 (metabolism)
  • Male
  • NF-kappa B (metabolism)
  • Parathyroid Hormone-Related Protein (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphorylation
  • Prostatic Neoplasms (metabolism, pathology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Receptor, Parathyroid Hormone, Type 1 (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: